Open Access
Research Article
Issue
Parasite
Volume 23, 2016
Article Number 12
Number of page(s) 10
DOI https://doi.org/10.1051/parasite/2016012
Published online 16 March 2016
  1. Blader IJ, Manger ID, Boothroyd JC. 2001. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. Journal of Biological Chemistry, 276(26), 24223–242231. [CrossRef] [PubMed] [Google Scholar]
  2. Boothroyd JC. 2009. Toxoplasma gondii: 25 years and 25 major advances for the field. International Journal for Parasitology, 39(8), 935–946. [CrossRef] [PubMed] [Google Scholar]
  3. Carme B, Ajzenberg D, Demar M, Simon S, Darde ML, Maubert B, de Thoisy B. 2009. Outbreaks of toxoplasmosis in a captive breeding colony of squirrel monkeys. Veterinary Parasitology, 163(1–2), 132–35. [CrossRef] [PubMed] [Google Scholar]
  4. Chardes T, Bout D. 1993. Mucosal immune response in toxoplasmosis. Immunologic Research, 144(1), 57–60. [CrossRef] [Google Scholar]
  5. Chevalier N, Rigden DJ, Van Roy J, Opperdoes FR, Michels PA. 2000. Trypanosoma brucei contains a 2,3-bisphosphoglycerate independent phosphoglycerate mutase. European Journal of Biochemistry, 267(5), 1464–1472. [CrossRef] [Google Scholar]
  6. Cisney ED, Fernandez S, Hall SI, Krietz GA, Ulrich RG. 2012. Examining the role of nasopharyngeal-associated lymphoreticular tissue (NALT) in mouse responses to vaccines. Jove-Journal of Visualized Experiments (66), 3960. [Google Scholar]
  7. Cong H, Zhang M, Xin Q, Wang Z, Li Y, Zhao Q, Zhou H, He S. 2013. Compound DNA vaccine encoding SAG1/SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii. Parasites & Vectors, 6, 63. [CrossRef] [PubMed] [Google Scholar]
  8. Costa-Silva TA, Borges MM, Galhardo CS, Pereira-Chioccola VL. 2012. Immunization with excreted/secreted proteins in AS/n mice activating cellular and humoral response against Toxoplasma gondii infection. Acta Tropica, 124(3), 203–209. [CrossRef] [PubMed] [Google Scholar]
  9. Dubey JP. 2005. Unexpected oocyst shedding by cats fed Toxoplasma gondii tachyzoites: in vivo stage conversion and strain variation. Veterinary Parasitology, 133(4), 289–298. [CrossRef] [PubMed] [Google Scholar]
  10. Dubey JP, Lindsay DS, Speer CA. 1998. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clinical Microbiology Reviews, 11(2), 267–299. [PubMed] [Google Scholar]
  11. Dupont CD, Christian DA, Hunter CA. 2012. Immune response and immunopathology during toxoplasmosis. Seminars in Immunopathology, 34(6), 793–813. [CrossRef] [PubMed] [Google Scholar]
  12. Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H. 2012. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice. Experimental Parasitology, 131(1), 133–138. [CrossRef] [PubMed] [Google Scholar]
  13. el-On J, Peiser J. 2003. Toxoplasma and toxoplasmosis. Harefuah, 142(1), 48–55, 77. [PubMed] [Google Scholar]
  14. Fleige T, Fischer K, Ferguson DJ, Gross U, Bohne W. 2007. Carbohydrate metabolism in the Toxoplasma gondii apicoplast: localization of three glycolytic isoenzymes, the single pyruvate dehydrogenase complex, and a plastid phosphate translocator. Eukaryotic Cell, 6(6), 984–996. [CrossRef] [PubMed] [Google Scholar]
  15. Gazzinelli RT, Denkers EY, Sher A. 1993. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infectious Agents and Disease, 2(3), 139–149. [PubMed] [Google Scholar]
  16. Halonen SK, Weiss LM. 2013. Toxoplasmosis. Handbook of Clinical Neurology, 114, 125–145. [CrossRef] [PubMed] [Google Scholar]
  17. Hiszczynska-Sawicka E, Gatkowska JM, Grzybowski MM, Dlugonska H. 2014. Veterinary vaccines against toxoplasmosis. Parasitology, 141(11), 1365–1378. [CrossRef] [PubMed] [Google Scholar]
  18. Huang X, Li J, Zhang G, Gong P, Yang J, Zhang X. 2012. Toxoplasma gondii: protective immunity against toxoplasmosis with recombinant actin depolymerizing factor protein in BALB/c mice. Experimental Parasitology, 130(3), 218–222. [CrossRef] [PubMed] [Google Scholar]
  19. Hutchings AB, Helander A, Silvey KJ, Chandran K, Lucas WT, Nibert ML, Neutra MR. 2004. Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer’s patches. Journal of Virology, 78(2), 947–957. [CrossRef] [PubMed] [Google Scholar]
  20. Innes EA, Bartley PM, Maley S, Katzer F, Buxton D. 2009. Veterinary vaccines against Toxoplasma gondii. Memorias do Instituto Oswaldo Cruz, 104(2), 246–251. [CrossRef] [Google Scholar]
  21. Jedrzejas MJ. 2000. Structure, function, and evolution of phosphoglycerate mutases: comparison with fructose-2,6-bisphosphatase, acid phosphatase, and alkaline phosphatase. Progress in Biophysics & Molecular Biology, 73(2–4), 263–287. [CrossRef] [Google Scholar]
  22. Jongert E, Melkebeek V, De Craeye S, Dewit J, Verhelst D, Cox E. 2008. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine, 26(8), 1025–1031. [CrossRef] [PubMed] [Google Scholar]
  23. Ju CH, Chockalingam A, Leifer CA. 2009. Early response of mucosal epithelial cells during Toxoplasma gondii infection. Journal of Immunology, 183(11), 7420–7427. [CrossRef] [Google Scholar]
  24. Kasper L, Courret N, Darche S, Luangsay S, Mennechet F, Minns L, Rachinel N, Ronet C, Buzoni-Gatel D. 2004. Toxoplasma gondii and mucosal immunity. International Journal for Parasitology, 34(3), 401–409. [CrossRef] [PubMed] [Google Scholar]
  25. LaRosa DF, Stumhofer JS, Gelman AE, Rahman AH, Taylor DK, Hunter CA, Turka LA. 2008. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proceedings of the National Academy of Sciences of the United States of America, 105(10), 3855–3860. [CrossRef] [PubMed] [Google Scholar]
  26. Lefrancois L, Lycke N. 2001. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer’s patch, and lamina propria cells. Current Protocols in Immunology, Chapter 3, Unit 3.19. [Google Scholar]
  27. Ma GY, Zhang JZ, Yin GR, Zhang JH, Meng XL, Zhao F. 2009. Toxoplasma gondii: proteomic analysis of antigenicity of soluble tachyzoite antigen. Experimental Parasitology, 122(1), 41–46. [CrossRef] [PubMed] [Google Scholar]
  28. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS, De Carli M, Ricci M, Romagnani S. 1992. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. Journal of Immunology, 148(7), 2142–2147. [Google Scholar]
  29. Mantis NJ, Forbes SJ. 2010. Secretory IgA: arresting microbial pathogens at epithelial borders. Immunological Investigations, 39(4–5), 383–406. [CrossRef] [PubMed] [Google Scholar]
  30. Montufar-Solis D, Klein JR. 2006. An improved method for isolating intraepithelial lymphocytes (IELs) from the murine small intestine with consistently high purity. Journal of Immunological Methods, 308(1–2), 251–254. [CrossRef] [PubMed] [Google Scholar]
  31. Moreno-Sanchez R, Encalada R, Marin-Hernandez A, Saavedra E. 2008. Experimental validation of metabolic pathway modeling. Febs Journal, 275(13), 3454–3469. [CrossRef] [Google Scholar]
  32. Noor S, Habashy AS, Nance JP, Clark RT, Nemati K, Carson MJ, Wilson EH. 2010. CCR7-dependent immunity during acute Toxoplasma gondii infection. Infection and Immunity, 78(5), 2257–2263. [CrossRef] [PubMed] [Google Scholar]
  33. Okomo-Adhiambo M, Beattie C, Rink A. 2006. cDNA microarray analysis of host-pathogen interactions in a porcine in vitro model for Toxoplasma gondii infection. Infection and Immunity, 74(7), 4254–4265. [CrossRef] [PubMed] [Google Scholar]
  34. Penarete-Vargas DM, Mevelec MN, Dion S, Seche E, Dimier-Poisson I, Fandeur T. 2010. Protection against lethal Neospora caninum infection in mice induced by heterologous vaccination with a mic1 mic3 knockout Toxoplasma gondii strain. Infection and Immunity, 78(2), 651–660. [CrossRef] [PubMed] [Google Scholar]
  35. Sa Q, Woodward J, Suzuki Y. 2013. IL-2 produced by CD8+ immune T cells can augment their IFN-gamma production independently from their proliferation in the secondary response to an intracellular pathogen. Journal of Immunology, 190(5), 2199–2207. [CrossRef] [Google Scholar]
  36. Saadatnia G, Mohamed Z, Ghaffarifar F, Osman E, Moghadam ZK, Noordin R. 2012. Toxoplasma gondii excretory secretory antigenic proteins of diagnostic potential. APMIS, 120(1), 47–55. [CrossRef] [PubMed] [Google Scholar]
  37. Suzuki Y. 2002. Host resistance in the brain against Toxoplasma gondii. Journal of Infectious Diseases, 185(Suppl 1), S58–S65. [CrossRef] [Google Scholar]
  38. Suzuki Y, Conley FK, Remington JS. 1989. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. Journal of Immunology, 143(6), 2045–2050. [Google Scholar]
  39. Suzuki Y, Yang Q, Yang S, Nguyen N, Lim S, Liesenfeld O, Kojima T, Remington JS. 1996. IL-4 is protective against development of toxoplasmic encephalitis. Journal of Immunology, 157(6), 2564–2569. [Google Scholar]
  40. Tan F, Hu X, Luo FJ, Pan CW, Chen XG. 2011. Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II. Vaccine, 29(15), 2742–2748. [CrossRef] [PubMed] [Google Scholar]
  41. Tenter AM, Heckeroth AR, Weiss LM. 2000. Toxoplasma gondii: from animals to humans. International Journal for Parasitology, 30(12–13), 1217–1258. [CrossRef] [PubMed] [Google Scholar]
  42. Turner TL, Nguyen VH, McLauchlan CC, Dymon Z, Dorsey BM, Hooker JD, Jones MA. 2012. Inhibitory effects of decavanadate on several enzymes and Leishmania tarentolae in vitro. Journal of Inorganic Biochemistry, 108, 96–104. [CrossRef] [PubMed] [Google Scholar]
  43. Velge-Roussel F, Marcelo P, Lepage AC, Buzoni-Gatel D, Bout DT. 2000. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infection and Immunity, 68(2), 969–972. [CrossRef] [PubMed] [Google Scholar]
  44. Verma R, Khanna P. 2013. Development of Toxoplasma gondii vaccine: a global challenge. Human Vaccines & Immunotherapeutics, 9(2), 291–293. [CrossRef] [PubMed] [Google Scholar]
  45. Wang HL, Li YQ, Yin LT, Meng XL, Guo M, Zhang JH, Liu HL, Liu JJ, Yin GR. 2013. Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis. PLoS One, 8(8), e70884. [CrossRef] [PubMed] [Google Scholar]
  46. Wu HY, Russell MW. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infection and Immunity, 61(1), 314–322. [PubMed] [Google Scholar]
  47. Yin GR, Meng XL, Ma GY, Ma XM. 2007. Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, 25(4), 290–294. [PubMed] [Google Scholar]
  48. Yin LT, Wang F, Meng XL, Wang HL, Liu HL, Shen JY, Yin GR. 2012. Cloning, expression and antigenicity analysis of phosphoglycerate mutase 2 gene of Toxoplasma gondii. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, 30(2), 86–89. [PubMed] [Google Scholar]
  49. Yin LT, Hao HX, Wang HL, Zhang JH, Meng XL, Yin GR. 2013. Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis. PLoS One, 8(12), e82765. [CrossRef] [PubMed] [Google Scholar]
  50. Yu H, Huang B, Zhuo X, Chen X, Du A. 2013. Evaluation of a real-time PCR assay based on the single-copy SAG1 gene for the detection of Toxoplasma gondii. Veterinary Parasitology, 197(3–4), 670–673. [CrossRef] [PubMed] [Google Scholar]
  51. Zhang NZ, Chen J, Wang M, Petersen E, Zhu XQ. 2013. Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Review of Vaccines, 12(11), 1287–1299. [CrossRef] [PubMed] [Google Scholar]
  52. Zhang NZ, Wang M, Xu Y, Petersen E, Zhu XQ. 2015. Recent advances in developing vaccines against Toxoplasma gondii: an update. Expert Review of Vaccines, 14(12), 1609–1621. [CrossRef] [PubMed] [Google Scholar]
  53. Zhang TE, Yin LT, Li RH, Wang HL, Meng XL, Yin GR. 2015. Protective immunity induced by peptides of AMA1, RON2 and RON4 containing T-and B-cell epitopes via an intranasal route against toxoplasmosis in mice. Parasites & Vectors, 8, 15. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.